Your browser doesn't support javascript.
loading
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Mangiante, Lise; Alcala, Nicolas; Sexton-Oates, Alexandra; Di Genova, Alex; Gonzalez-Perez, Abel; Khandekar, Azhar; Bergstrom, Erik N; Kim, Jaehee; Liu, Xiran; Blazquez-Encinas, Ricardo; Giacobi, Colin; Le Stang, Nolwenn; Boyault, Sandrine; Cuenin, Cyrille; Tabone-Eglinger, Severine; Damiola, Francesca; Voegele, Catherine; Ardin, Maude; Michallet, Marie-Cecile; Soudade, Lorraine; Delhomme, Tiffany M; Poret, Arnaud; Brevet, Marie; Copin, Marie-Christine; Giusiano-Courcambeck, Sophie; Damotte, Diane; Girard, Cecile; Hofman, Veronique; Hofman, Paul; Mouroux, Jérôme; Cohen, Charlotte; Lacomme, Stephanie; Mazieres, Julien; de Montpreville, Vincent Thomas; Perrin, Corinne; Planchard, Gaetane; Rousseau, Nathalie; Rouquette, Isabelle; Sagan, Christine; Scherpereel, Arnaud; Thivolet, Francoise; Vignaud, Jean-Michel; Jean, Didier; Ilg, Anabelle Gilg Soit; Olaso, Robert; Meyer, Vincent; Boland-Auge, Anne; Deleuze, Jean-Francois; Altmuller, Janine; Nuernberg, Peter.
Affiliation
  • Mangiante L; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Alcala N; Department of Medicine, Stanford University, Stanford, CA, USA.
  • Sexton-Oates A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Di Genova A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Gonzalez-Perez A; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Khandekar A; Instituto de Ciencias de la Ingeniería, Universidad de O'Higgins, Rancagua, Chile.
  • Bergstrom EN; Centro de Modelamiento Matemático UMI-CNRS 2807, Universidad de Chile, Santiago, Chile.
  • Kim J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Liu X; Centro de Investigación Biomédica en Red en Cáncer, Instituto de Salud Carlos III, Madrid, Spain.
  • Blazquez-Encinas R; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Giacobi C; Department of Cellular and Molecular Medicine, Department of Bioengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Le Stang N; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA.
  • Boyault S; Department of Computational Biology, Cornell University, Ithaca, NY, USA.
  • Cuenin C; Institute for Computational and Mathematical Engineering, Stanford University, Stanford, CA, USA.
  • Tabone-Eglinger S; Maimonides Biomedical Research Institute of Cordoba, Córdoba, Spain.
  • Damiola F; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Córdoba, Spain.
  • Voegele C; Reina Sofia University Hospital, Córdoba, Spain.
  • Ardin M; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain.
  • Michallet MC; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Soudade L; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.
  • Delhomme TM; Cancer Genomic Platform, Translational Research and Innovation Department, Centre Léon Bérard, Lyon, France.
  • Poret A; EpiGenomics and Mechanisms Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Brevet M; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.
  • Copin MC; UMR INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, MESOPATH-MESOBANK, Department of Biopathology, Cancer Centre Léon Bérard, Lyon, France.
  • Giusiano-Courcambeck S; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Damotte D; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Girard C; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.
  • Hofman V; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Hofman P; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Mouroux J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Cohen C; Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France.
  • Lacomme S; Cypath and Cypath-rb, Villeurbanne, France.
  • Mazieres J; University of Lille, Centre Hospitalier Universitaire Lille, Institut de Pathologie, Tumorothèque du Centre de Référence Régional en Cancérologie, Lille, France.
  • de Montpreville VT; Department of Pathology, Centre Hospitalier Universitaire Nord, Marseille, France.
  • Perrin C; Centre de Recherche des Cordeliers, Inflammation, Complement and Cancer Team, Sorbonne Université, INSERM, Université de Paris, Paris, France.
  • Planchard G; Department of Pathology, Hôpitaux Universitaire Paris Centre, Tumorothèque/CRB Cancer, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Rousseau N; Tumorothèque Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Rouquette I; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, Nice Center Hospital, FHU OncoAge, Biobank BB-0033-00025 and IRCAN Inserm U1081/CNRS 7284, Nice, France.
  • Sagan C; Université Côte d'Azur, Laboratory of Clinical and Experimental Pathology, Nice Center Hospital, FHU OncoAge, Biobank BB-0033-00025 and IRCAN Inserm U1081/CNRS 7284, Nice, France.
  • Scherpereel A; Université Côte d'Azur, Department of Thoracic Surgery, Nice Center Hospital, FHU OncoAge and IRCAN Inserm U1081/CNRS 7284, Nice, France.
  • Thivolet F; Department of Thoracic Surgery, FHU OncoAge, Nice Pasteur Hospital, Université Côte d'Azur, Nice, France.
  • Vignaud JM; Nancy Regional University Hospital, Centre Hospitalier Régional Universitaire, CRB BB-0033-00035, INSERM U1256, Nancy, France.
  • Jean D; Toulouse University Hospital, Université Paul Sabatier, Toulouse, France.
  • Ilg AGS; Department of Pathology, Marie Lannelongue Hospital, Le Plessis Robinson, France.
  • Olaso R; Hospices Civils de Lyon, Institut de Pathologie, Centre de Ressources Biologiques des HCL, Tissu-Tumorothèque Est, Lyon, France.
  • Meyer V; Centre Hospitalier Universitaire de Caen, MESOPATH Regional Center, Caen, France.
  • Boland-Auge A; Centre Hospitalier Universitaire de Caen, MESOPATH Regional Center, Caen, France.
  • Deleuze JF; Centre de Pathologie des Côteaux, Centre de Ressources Biologiques (CRB Cancer), IUCT Oncopole, Toulouse, France.
  • Altmuller J; Tumorothèque Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Nuernberg P; University of Lille, Centre Hospitalier Universitaire Lille, INSERM, OncoThAI, NETMESO Network, Lille, France.
Nat Genet ; 55(4): 607-618, 2023 04.
Article in En | MEDLINE | ID: mdl-36928603
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos